FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:2191-2193 May 20, 2004 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Lynch, T. J. PubMed Citation

The emergence of effective cancer chemotherapy is one of the major medical advances of the second half of the 20th century. In certain neoplasms — such as gestational choriocarcinoma, childhood acute lymphoblastic leukemia, and subgroups of Hodgkin's disease and non-Hodgkin's lymphoma — chemotherapy is often curative, and the promise of long-term survival makes therapy well worth the risk of adverse effects and the financial costs. Moreover, adjuvant chemotherapy for breast, colon, or lung cancer can augment the survival benefit afforded by surgical management. Even in patients with advanced solid tumors or recurrences despite surgery, chemotherapy can offer lengthened survival of . . . [Full Text of this Article]

Source Information

From the Hollings Cancer Center and the Department of Medicine, Medical University of South Carolina, Charleston.

This editorial was published at www.nejm.org on April 29, 2004.

This article has been cited by other articles:

• Pintens, S, Neven, P, Drijkoningen, M, Van Belle, V, Moerman, P, Christiaens, M-R, Smeets, A, Wildiers, H, Bempt, I V. (2009). Triple negative breast cancer: a study from the point of view of basal CK5/6 and HER-1. J. Clin. Pathol. 62: 624-628 [Abstract] [Full Text]  
• Overdevest, J. B., Theodorescu, D., Lee, J. K. (2009). Utilizing the Molecular Gateway: The Path to Personalized Cancer Management. Clin. Chem. 55: 684-697 [Abstract] [Full Text]  
• Saxena, N. K., Taliaferro-Smith, L., Knight, B. B., Merlin, D., Anania, F. A., O'Regan, R. M., Sharma, D. (2008). Bidirectional Crosstalk between Leptin and Insulin-like Growth Factor-I Signaling Promotes Invasion and Migration of Breast Cancer Cells via Transactivation of Epidermal Growth Factor Receptor. Cancer Res. 68: 9712-9722 [Abstract] [Full Text]  
• Schwartz, A. M., Henson, D. E. (2007). Diagnostic Surgical Pathology in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest 132: 78S-93S [Abstract] [Full Text]  
• Verlinden, L., Vanden Bempt, I., Eelen, G., Drijkoningen, M., Verlinden, I., Marchal, K., De Wolf-Peeters, C., Christiaens, M.-R., Michiels, L., Bouillon, R., Verstuyf, A. (2007). The E2F-Regulated Gene Chk1 Is Highly Expressed in Triple-Negative Estrogen Receptor /Progesterone Receptor /HER-2 Breast Carcinomas. Cancer Res. 67: 6574-6581 [Abstract] [Full Text]  
• Lynch, T. J., Adjei, A. A., Bunn, P. A. Jr., Eisen, T. G., Engelman, J., Goss, G. D., Haber, D. A., Heymach, J. V., Janne, P. A., Johnson, B. E., Johnson, D. H., Lilenbaum, R. C., Meyerson, M., Sandler, A. B., Sequist, L. V., Settleman, J., Wong, K.-K., Hart, C. S. (2006). Novel agents in the treatment of lung cancer: advances in EGFR-targeted agents. Proceedings of the Third Cambridge Conference. September 23-24, 2005. Cambridge, Massachusetts, USA.. Clin. Cancer Res. 12: 4365s-4457s [Full Text]  
• Nicolle, G., Daher, A., Maille, P., Vermey, M., Loric, S., Bakkar, A., Wallerand, H., Vordos, D., Vacherot, F., de Medina, S. G. D., Abbou, C. C., Kwast, T. V. d., Thiery, J.-P., Radvanyi, F., Chopin, D. K. (2006). Gefitinib Inhibits the Growth and Invasion of Urothelial Carcinoma Cell Lines in which Akt and MAPK Activation Is Dependent on Constitutive Epidermal Growth Factor Receptor Activation.. Clin. Cancer Res. 12: 2937-2943 [Abstract] [Full Text]  
• Marie, Y., Carpentier, A. F., Omuro, A.M.P., Sanson, M., Thillet, J., Hoang-Xuan, K., Delattre, J. -Y. (2005). EGFR tyrosine kinase domain mutations in human gliomas. Neurology 64: 1444-1445 [Abstract] [Full Text]  
• de Braud, F., De Pas, T., Spaggiari, L., Veronesi, G., Curigliano, G., Noberasco, C., Pelosi, G. (2005). Re: Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non-Small-Cell Lung Cancer. JNCI J Natl Cancer Inst 97: 461-462 [Full Text]  
• Marchetti, A., Martella, C., Felicioni, L., Barassi, F., Salvatore, S., Chella, A., Camplese, P. P., Iarussi, T., Mucilli, F., Mezzetti, A., Cuccurullo, F., Sacco, R., Buttitta, F. (2005). EGFR Mutations in Non-Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment. JCO 23: 857-865 [Abstract] [Full Text]  
• Fukuoka, M. (2005). In Reply:. JCO 23: 922-922 [Full Text]